Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,267 | 539 | 95.6% |
| Education | $330.87 | 4 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,410 | 105 | $0 (2024) |
| ABBVIE INC. | $940.09 | 88 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $910.12 | 45 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $674.31 | 63 | $0 (2024) |
| Lilly USA, LLC | $464.21 | 36 | $0 (2024) |
| PFIZER INC. | $285.92 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $230.08 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $215.76 | 10 | $0 (2024) |
| Antares Pharma, Inc. | $204.16 | 13 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $198.84 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,914 | 123 | ABBVIE INC. ($249.11) |
| 2023 | $1,834 | 132 | Novo Nordisk Inc ($271.38) |
| 2022 | $2,050 | 144 | Novo Nordisk Inc ($581.80) |
| 2021 | $1,800 | 144 | Novo Nordisk Inc ($312.31) |
All Payment Transactions
543 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Obesity | ||||||
| 12/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: VACCINES | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.28 | General |
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX, AREXVY | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.56 | General |
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 82 | 95 | $14,325 | $3,493 |
| 2022 | 4 | 122 | 150 | $22,200 | $5,898 |
| 2021 | 3 | 100 | 119 | $17,050 | $5,953 |
| 2020 | 3 | 69 | 82 | $11,350 | $3,309 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 40 | $7,000 | $1,770 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 34 | $6,800 | $1,546 | 22.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 21 | $525.00 | $176.40 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 62 | $10,850 | $2,826 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 42 | $8,400 | $2,195 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 12 | 12 | $2,100 | $776.32 | 37.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 30 | 34 | $850.00 | $100.77 | 11.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 53 | $9,275 | $3,015 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 35 | $7,000 | $2,846 | 40.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 27 | 31 | $775.00 | $93.00 | 12.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 36 | $7,200 | $2,347 | 32.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 20 | $3,500 | $885.32 | 25.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 24 | 26 | $650.00 | $77.10 | 11.9% |
About Daniel Carducci, P.A
Daniel Carducci, P.A is a Medical healthcare provider based in Flemington, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1669812731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Carducci, P.A has received a total of $7,597 in payments from pharmaceutical and medical device companies, with $1,914 received in 2024. These payments were reported across 543 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,267).
As a Medicare-enrolled provider, Carducci has provided services to 373 Medicare beneficiaries, totaling 446 services with total Medicare billing of $18,653. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Flemington, NJ
- Active Since 07/03/2013
- Last Updated 04/08/2014
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1669812731
Products in Payments
- XIFAXAN (Drug) $674.31
- FARXIGA (Drug) $566.53
- Ozempic (Drug) $510.63
- Wegovy (Drug) $455.92
- UBRELVY (Drug) $392.39
- VRAYLAR (Drug) $294.94
- Saxenda (Drug) $269.77
- REXULTI (Drug) $262.52
- BREZTRI (Drug) $252.07
- QULIPTA (Drug) $243.03
- NURTEC ODT (Drug) $234.93
- CAPLYTA (Drug) $214.18
- TRULICITY (Drug) $194.36
- TRELEGY ELLIPTA (Drug) $172.01
- MOUNJARO (Drug) $171.38
- TRINTELLIX (Drug) $128.81
- XYOSTED (Drug) $126.25
- SUNOSI (Drug) $112.02
- Veozah (Drug) $111.22
- JARDIANCE (Drug) $110.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Flemington
Jonathan Rhoads, Pa, PA
Medical — Payments: $3,227
Frederick Banerman, Pa-C, PA-C
Medical — Payments: $2,823
Lauralee Pakozdi, Ms,Pa-C, MS,PA-C
Medical — Payments: $1,225
Jennifer Herbstritt, Pa-C, PA-C
Medical — Payments: $235.71
Esther Wasserstein, Pa, PA
Medical — Payments: $184.73
Cailyn Hillier, Pa-C, PA-C
Medical — Payments: $122.34